Revenue Continues to Accelerate, Increasing 53% in First Half of FY2024
2023 net revenue of $2.83M, up 276% versus prioryear due to major retailer engagements
BioStem CEO, Jason Matuszewski, will present on Tuesday, April 9, 2024, at 12:30 pm ET